Breakthrough gene expression search engine for cost reduction and significantly increased use of open data in drug discovery.

Project Information

XPRESSO

Grant agreement ID: 673405

DOI 10.3030/673405

Project closed

EC signature date 27 April 2015

Start date 1 May 2015

End date 31 October 2015

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

MEDICAL TECHNOLOGY GROUP OU
Estonia

Objective

Breakthrough gene expression search engine for cost reduction and significantly increased use of open data in drug discovery. We are putting the power of genetic data analytics into the cloud and providing this as an easy to access service to biologists via a search engine. The challenge today is that as the field of sequencing is developing at a rapid pace and the amount of genetic data is exploding, nobody really can analyze all that data and pull it up when needed for making informed decision in the field of drug development and life science research. We are seizing this business opportunity through our competitive edge by creating an easily usable cloud-based gene expression search engine on top of publicly available datasets that have been analyzed and indexed by our advanced algorithms. This allows for providing unexpected discoveries in the field of drug discovery at a significantly reduced rate and insight, which has not been possible before. 

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery

You need to log in or register to use this function

Programme(s)

• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Topic(s)

• ICT-37-2014-1 - Open Disruptive Innovation Scheme (implemented through the SME instrument)

Call for proposal

H2020-SMEInst-2014-2015

See other projects for this call

Sub call

H2020-SMEINST-1-2014

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

MEDICAL TECHNOLOGY GROUP OU

• Net EU contribution: € 50 000,00
• Address: RAVALA 8 ; 10143 TALLINN ; Estonia
• SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes:
  Region
  Eesti › Eesti › Põhja-Eesti
• Region: Eesti › Eesti › Põhja-Eesti
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Total cost: € 71 429,00